Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 22.92B | 24.86B | 22.09B | 21.07B | 21.19B | 20.95B |
Gross Profit | 5.60B | 6.16B | 5.35B | 4.47B | 4.57B | 4.34B |
EBITDA | 2.18B | 3.15B | 2.72B | 2.28B | 2.29B | 2.04B |
Net Income | 846.32M | 1.38B | 936.47M | 682.48M | 638.17M | 497.04M |
Balance Sheet | ||||||
Total Assets | 19.98B | 21.58B | 20.82B | 20.12B | 18.60B | 19.13B |
Cash, Cash Equivalents and Short-Term Investments | 5.80B | 5.69B | 6.59B | 5.88B | 5.40B | 4.54B |
Total Debt | 1.76B | 1.65B | 2.05B | 2.06B | 1.38B | 1.55B |
Total Liabilities | 5.86B | 6.92B | 6.97B | 6.68B | 5.69B | 6.62B |
Stockholders Equity | 14.12B | 14.66B | 13.85B | 13.44B | 12.91B | 12.50B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 386.01M | 1.70B | 1.09B | 1.58B | 1.05B |
Operating Cash Flow | 0.00 | 742.04M | 2.51B | 1.71B | 2.12B | 1.75B |
Investing Cash Flow | 0.00 | -608.45M | -595.27M | -475.22M | -518.83M | -702.38M |
Financing Cash Flow | 0.00 | -1.03B | -1.20B | -756.48M | -744.15M | -699.29M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥13.46B | 9.54 | 3.97% | 10.04% | 99.20% | ||
79 Outperform | ¥13.84B | 10.68 | 3.86% | 2.13% | 7.67% | ||
78 Outperform | ¥15.76B | 7.83 | 3.93% | 7.93% | 20.67% | ||
76 Outperform | ¥16.94B | 12.05 | 1.62% | 12.54% | 52.37% | ||
75 Outperform | ¥15.60B | 10.81 | 3.23% | 8.46% | 3.01% | ||
69 Neutral | ¥228.87B | 14.07 | 7.50% | 2.70% | 9.25% | 8.21% | |
68 Neutral | ¥13.62B | 20.08 | 3.68% | -2.98% | -31.07% |